Omeprazol y clopidogrel asociado a trombosis de stent / Omeprazole and Clopidogrel associated to stent thrombosis
Rev. cuba. med
; 52(2): 139-143, abr.-jun. 2013.
Article
in Es
| LILACS
| ID: lil-678125
Responsible library:
CU1.1
RESUMEN
El clopidogrel es un fármaco empleado en la prevención de complicaciones aterotrombóticas en pacientes que han sufrido infarto de miocardio, así como en terapia combinada con el ácido acetilsalicílico en pacientes que les será colocado stent tras angioplastia transluminar percutánea, por lo cual debe tomarse en cuenta cuando se asocia con omeprazol por su efecto inhibitorio antiagregante del clopidogrel. Se presentó un caso de trombosis aguda de stent como consecuencia de la interacción entre estos medicamentos
ABSTRACT
Clopidogrel is a drug which is used in the prevention of atherothombotic complications in patients that have suffered from myocardial infarction and in the combined therapy with the acetylsalcylic acid in patients to whom a stent after percutaneous transluminal coronary angioplasty has been placed. The antiaggregant inhibition effect of clopidogrel should be kept in mind when it is associated to omeprazol. Here, we present a clinical case about acute stent thrombosis as a consequence of the interaction of these drugs
Key words
Full text:
1
Index:
LILACS
Main subject:
Omeprazole
/
Angioplasty
/
Myocardial Infarction
Type of study:
Risk_factors_studies
Limits:
Female
/
Humans
/
Male
Language:
Es
Journal:
Rev. cuba. med
Journal subject:
MEDICINA
Year:
2013
Type:
Article